PF-07832837 is under clinical development by Pfizer and currently in Phase I for Asthma. According to GlobalData, Phase I drugs for Asthma have a 74% phase transition success rate (PTSR) indication ...

Bempikibart (ADX-914) is under development for the treatment of atopic dermatitis and alopecia areata. It is administered through subcutaneous route and acts by targeting interleukin-7 receptor (IL-7R ...

VANCOUVER, British Columbia, Dec. 31, 2024 (GLOBE NEWSWIRE) -- VERSES AI Inc. (CBOE:VERS) (OTCQB:VRSSF) ("VERSES'' or the ...

Bloomberg Green looks at how energy markets, consumer spending and diplomacy will shape the future of the planet this year.

VERSES AI Inc. (CBOE:VERS) (OTCQB:VRSSF) ("VERSES' or the "Company"), a cognitive computing company specializing in next generation intelligent ...

Moderna/Merck partnership and its potential in personalised cancer therapies are good opportunities for long-term investors.

The S&P 500's returns are measured using time-weighted returns (TWR), which don't account for cash flows like withdrawals. If you're retired and withdrawing funds, comparing your portfolio to the S&P ...

As 2024 ends, India’s AI sector has transitioned from its experimentation stage to strategic adoption, primarily driven by ...

At the January 2025 reinsurance renewals broking group Howden estimates that risk-adjusted pricing for property catastrophe ...

As with any technological advancement, there are problems with current artificial intelligence systems. According to VERSES ...

Key predictions from data infrastructure industry experts and vendors to help enterprises tap the AI opportunity for growth in 2025.

Street photographer Christopher Ward has amassed more than a million followers by capturing the wisdom of strangers in ...